Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
NA-921 by Biomed Industries for Fragile X Syndrome: Likelihood of Approval
NA-921 is under clinical development by Biomed Industries and currently in Phase III for Fragile X Syndrome. According to GlobalData,...
Data Insights
NA-921 by Biomed Industries for Rett Syndrome: Likelihood of Approval
NA-921 is under clinical development by Biomed Industries and currently in Phase III for Rett Syndrome. According to GlobalData, Phase...